Beclometasone/formoterol/glycopyrronium bromide
Combination drug / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Beclometasone/formoterol/glycopyrronium bromide?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Beclometasone/formoterol/glycopyrronium, sold under the brand name Trimbow among others, is an inhalable fixed-dose combination medication for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It contains beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide.[3][4]
Quick Facts Combination of, Formoterol fumarate dihydrate ...
Combination of | |
---|---|
Beclometasone dipropionate | Glucocorticoid |
Formoterol fumarate dihydrate | Long-acting β2 agonist |
Glycopyrronium bromide | Antimuscarinic |
Clinical data | |
Trade names | Trimbow, Trydonis, Riarify, others |
AHFS/Drugs.com | UK Drug Information |
Routes of administration | Inhalation |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number |
Close
Side effects include oral candidiasis (a fungal infection of the mouth caused by a yeast called Candida), muscle spasms and dry mouth.[3][4]
Beclometasone/formoterol/glycopyrronium was approved for use in the European Union in July 2017, and in April 2018.[3][4][5]